caffeine and sodium benzoate

Generic: caffeine and sodium benzoate

Labeler: american regent, inc.
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name caffeine and sodium benzoate
Generic Name caffeine and sodium benzoate
Labeler american regent, inc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

caffeine 125 mg/mL

Manufacturer
American Regent, Inc.

Identifiers & Regulatory

Product NDC 0517-2502
Product ID 0517-2502_53245845-b446-46f8-bbe8-3323c58e10e5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 1993-02-01

Pharmacologic Class

Established (EPC)
central nervous system stimulant [epc] methylxanthine [epc]
Chemical Structure
xanthines [cs]
Physiologic Effect
central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05172502
Hyphenated Format 0517-2502

Supplemental Identifiers

UPC
0305172502100
UNII
3G6A5W338E
NUI
N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name caffeine and sodium benzoate (source: ndc)
Generic Name caffeine and sodium benzoate (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 125 mg/mL
source: ndc
Packaging
  • 10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) / 2 mL in 1 VIAL, SINGLE-DOSE (0517-2502-01)
source: ndc

Packages (1)

0517-2502-10 10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) / 2 mL in 1 VIAL, SINGLE-DOSE (0517-2502-01)

Ingredients (1)

caffeine (125 mg/mL)

Linked Drug Pages (1)

Caffeine and Sodium Benzoate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "53245845-b446-46f8-bbe8-3323c58e10e5", "openfda": {"nui": ["N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0305172502100"], "unii": ["3G6A5W338E"], "spl_set_id": ["b2c6b352-f837-4903-8e4c-fb0a2b20bb60"], "pharm_class_cs": ["Xanthines [CS]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "manufacturer_name": ["American Regent, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10)  / 2 mL in 1 VIAL, SINGLE-DOSE (0517-2502-01)", "package_ndc": "0517-2502-10", "marketing_start_date": "19930201"}], "brand_name": "Caffeine and Sodium Benzoate", "product_id": "0517-2502_53245845-b446-46f8-bbe8-3323c58e10e5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Methylxanthine [EPC]", "Xanthines [CS]"], "product_ndc": "0517-2502", "generic_name": "Caffeine and Sodium Benzoate", "labeler_name": "American Regent, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Caffeine and Sodium Benzoate", "active_ingredients": [{"name": "CAFFEINE", "strength": "125 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "19930201", "listing_expiration_date": "20261231"}